Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes
<p>Abstract</p> <p>Background</p> <p>The reduced drug accumulation based on enhanced drug efflux and metabolic capacity, identified in triclabendazole (TCBZ)-resistant <it>Fasciola hepatica </it>may contribute to the development of resistance to TCBZ. The ai...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-02-01
|
| Series: | BMC Veterinary Research |
| Online Access: | http://www.biomedcentral.com/1746-6148/6/8 |